Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatocellular Carcinoma Non-resectable × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 483 Neoplasms 417 Carcinoma, Non-Small-Cell Lung 368 Prostatic Neoplasms 306 Lung Neoplasms 235 Colorectal Neoplasms 225 Neoplasm Metastasis 191 Leukemia, Myeloid, Acute 188 Multiple Myeloma 176 Ovarian Neoplasms 163 Melanoma 152 Pancreatic Neoplasms 133 Brain Neoplasms 114 Squamous Cell Carcinoma of Head and Neck 112 Recurrence 111 Lymphoma 103 Carcinoma, Hepatocellular 98 Triple Negative Breast Neoplasms 96 Glioma 95 Glioblastoma 95 Endometrial Neoplasms 95 Uterine Cervical Neoplasms 94 Urinary Bladder Neoplasms 93 Carcinoma, Renal Cell 93 Stomach Neoplasms 92 Precursor Cell Lymphoblastic Leukemia-Lymphoma 90 Lymphoma, Non-Hodgkin 84 Hematologic Neoplasms 80 Leukemia, Lymphocytic, Chronic, B-Cell 79 Sarcoma 77

Interventions

rhenium-SSS-lipiodol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05797870 2026-03-19

Lip-Re2

Center Eugene Marquis

Phase 2 Suspended

Gastrointestinal

Hepatocellular Carcinoma Non-resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡